EQRx, Inc.

EQRx, Inc. (Nasdaq: EQRX) is a biopharmaceutical company that completed its business combination with CMLS Holdings, Inc. in January 2022, accessing public markets through the blank-check vehicle sponsored by CMS Holdings, LLC, which had conducted its IPO in 2021. Operating in the healthcare and pharmaceutical sector, EQRx was founded with a focus on developing and commercializing innovative medicines at substantially reduced prices relative to existing market benchmarks. As of its October 2022 Form 8-K filing, EQRx was active as a publicly traded company executing its post-merger commercial and pipeline strategy. Sign up on SpacDesk for full filings, sponsor data, and deal analytics on EQRX and the broader SPAC market.